Evidence map›Paper›PMID 40742124›Full record

ArticlemSphere2025

β-Nicotinamide mononucleotide protects against hypervirulent

Zubai Cao, Bao Meng, Jie Chen, Ruomu Ge, Yanyan Liu, Jiabin Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zubai CaoDepartment of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0002-8991-6677
Bao MengDepartment of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jie ChenDepartment of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ruomu GeDepartment of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yanyan LiuDepartment of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0002-5224-773X
Jiabin LiDepartment of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0002-6539-1802

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In clinical practice, hypervirulent

Indexed as

BacteremiaKlebsiella InfectionsKlebsiella pneumoniaeLiver AbscessNicotinamide MononucleotideAnimalsAnti-Bacterial AgentsDisease Models, AnimalLiverMacrophagesMaleMiceMice, Inbred C57BLNF-kappa BSignal TransductionVirulenceAnti-Bacterial AgentsNF-kappa BNicotinamide Mononucleotidebloodstream infectionhypervirulent Klebsiella pneumoniaeliver abscessNMN

Identifiers

PMID40742124
PMCPMC12379607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.